Literature DB >> 25765724

Infarct volume-based subgroup selection in acute ischemic stroke trials.

Anna Kufner1, Anke Wouters2, Luc Bracoud2, Rico Laage2, Armin Schneider2, Wolf-Rüdiger Schäbitz2, Marc Hermier2, Vincent Thijs2, Jochen B Fiebach2.   

Abstract

BACKGROUND AND
PURPOSE: We investigated whether hyperintensities with a diameter of at least 3, 3.5, and 4 cm and visible on at least 3 slices on diffusion-weighted imaging enables patient selection with an infarct volume of ≥15 mL.
METHODS: Consecutive acute stroke patients were screened for the AXIS2 trial and examined according to a standardized magnetic resonance imaging protocol in 65 sites. Diffusion-weighted lesion diameters were measured and compared with volumetric assessments.
RESULTS: Out of 238 patients, 86.2% (N=206) had infarct diameter of at least 3 cm. Volumetric assessments showed infarct volume of ≥15 mL in 157 patients. A cut-off value of 3 cm led to 96.8% sensitivity and 33.3% specificity for predicting lesion volume of ≥15 mL. Analogously, a 3.5 cm cut-off led to 96.8% sensitivity and 50.6% specificity and a 4 cm cut-off led to 91.7% sensitivity and 61.7% specificity.
CONCLUSIONS: Lesion diameter measures may enable multicentric patient recruitment with a prespecified minimal infarct volume. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00927836.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  clinical trial; infarction; stroke

Mesh:

Year:  2015        PMID: 25765724     DOI: 10.1161/STROKEAHA.114.008115

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  1 in total

1.  Reliability of Two Diameters Method in Determining Acute Infarct Size. Validation as New Imaging Biomarker.

Authors:  Jochen B Fiebach; Jonas D Stief; Ramanan Ganeshan; Benjamin Hotter; Ann-Christin Ostwaldt; Christian H Nolte; Kersten Villringer
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.